Clinical Trials

250 enrolled

Genitourinary

High-Risk Localized Prostate Cancer

NCT07527858 2026-04-14

Study of Denikitug (GS-1811) Given Alone or With Nivolumab or With Chemotherapy in Adults With Advanced Colorectal Cancer

170 enrolled

Advanced Microsatellite Stable Colorectal Cancer

NCT07529405 2026-04-14

CurbMF

386 enrolled

Lymphoid

Mycosis Fungoides

NCT07522476 2026-04-13

A Clinical Study to Evaluate the Efficacy and Safety of VG2025 in Intrahepatic Cholangiocarcinoma

30 enrolled

Cholangiocarcinoma

NCT07415031 2026-04-08

A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies

170 enrolled

Other solid neoplasm

Solid Tumors

NCT07513454 2026-04-07

A Phase 2 Study of HW211026 in Participants With Actinic Keratosis

80 enrolled

Keratosis, Actinic

NCT07390383 2026-04-01

A Phase II Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumour[Substudy 04]

110 enrolled

Other solid neoplasm

Advanced Solid Tumour

NCT07501702 2026-03-30

ETNA

30 enrolled

Myasthenia Gravis

NCT07287098 2026-03-27

preEMBER

600 enrolled

Breast Neoplasms

NCT07494435 2026-03-27

Phase 2 Study of WGI-0301 Plus Nivolumab in Patients With HCC and RCC

230 enrolled

Genitourinary

Carcinoma, Renal Cell

NCT07497074 2026-03-27

JSKN033 Combination Therapy in Subjects With Advanced Cervical Cancer

78 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT07497386 2026-03-27

A Trial of Trastuzumab Rezetecan in Unresectable Locally Recurrent/Metastatic Breast Cancer

150 enrolled

Unresectable Locally Recurrent Breast Cancer

NCT04910386 2026-03-25

Multicenter Phase 2 Study of Envafolimab in Biliary Tract Cancers

126 enrolled

Biliary Tract Neoplasms

NCT07492680 2026-03-25

A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)

CNSDermatologicGastrointestinal

260 enrolled

Brain Neoplasms, Melanoma, Pancreatic Neoplasms

NCT07489716 2026-03-24

A Phase II Clinical Trial of SHR-1826 for Non-Small Cell Lung Cancer

90 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07354074 2026-03-23

Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP

MyeloidOther hematologic neoplasm

50 enrolled

Bronchiolitis Obliterans Syndrome, Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT07486817 2026-03-23

Beamion 44: A Study to Test How Well Zongertinib is Tolerated by People With Advanced Non-small Cell Lung Cancer With HER2 Mutations When Given in Combination With Chemotherapy With or Without Pembrolizumab

Lung Neoplasms

NCT07487519 2026-03-23

Phase II Study of HLX43 Monotherapy or Combined With Immune Checkpoint Inhibitors in Patients With Locally Advanced, Recurrent, or Metastatic Triple-negative Breast Cancer.

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT07489066 2026-03-23

Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC

120 enrolled

Carcinoma, Carcinoma, Non-Small-Cell Lung, Lung Diseases, Lung Neoplasms

NCT06708455 2026-03-19

Phase 2b of RAPA-201 Cell Therapy in Post-PD-(L)-1 Melanoma

65 enrolled

Melanoma

NCT07483554 2026-03-19

IBI343 in Combination Therapy for Advanced Malignant Solid Tumors

389 enrolled

CLDN18.2 Positive

NCT07224672 2026-03-17

ALANIS

Plasma cell

Immunoglobulin Light-chain Amyloidosis, Amyloidosis

NCT07477366 2026-03-17

Study of CD19 t-haNK and NAI With Rituximab in Participants With Indolent Non-Hodgkin Lymphoma

20 enrolled

Lymphoid

Lymphoma, B-Cell

NCT07474727 2026-03-16

A Phase II Study of AMT-676 Combination Therapies in Advanced Colorectal Cancer

Colorectal Neoplasms

NCT07452224 2026-03-12

ILKN421H Plus Pembrolizumab in Advanced Non-Small Cell Lung Cancer

80 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07457164 2026-03-12

A Study Investigating the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Teverelix DP, a Gonadotropin-releasing Hormone (GnRH) Antagonist, in Patients With Advanced Prostate Cancer

40 enrolled

Genitourinary

Urogenital Diseases, Prostatic Diseases

NCT07465757 2026-03-12

ALISCA-Lung2

50 enrolled

Small Cell Lung Carcinoma

NCT05265052 2026-03-11

3D1002 in Combination With Oxycodone Hydrochloride Sustained-release Tablets in Patients With Moderate to Severe Cancer Pain

177 enrolled

Cancer Pain

NCT07227350 2026-03-10

L19IL2 or L19TNF or L19IL2/TNF in Patients With Basal Cell Carcinoma (BCC)

Carcinoma, Basal Cell

NCT07459634 2026-03-10

A Study of Lurbinectedin in Combination With Durvalumab for the Treatment of Participants With ES-SCLC

50 enrolled

Small Cell Lung Carcinoma

NCT07459738 2026-03-10

A Phase II Study to Evaluate the Efficacy and Safety of HLX43 in Patients With Hormone Receptor Positive, HER2 Negative Locally Advanced or Metastatic Breast Cancer

Breast Neoplasms

NCT07227870 2026-03-09

L19IL2/TNF in Patients With Basal Cell Carcinoma

92 enrolled

Carcinoma, Basal Cell

NCT07446322 2026-03-04

FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer

Ras-mutated Metastatic Colorectal Cancer

NCT07448922 2026-03-04

A Study of SKB518 as Monotherapy or Combination Therapy in Patients With Advanced Gynecological Malignant Tumors

290 enrolled

Advanced Gynecological Malignancies

NCT07444437 2026-03-03

LM103 in Phase IIa Clinical Trial for Adjuvant Treatment in Patients With Non-small Cell Lung Cancer

45 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07446049 2026-03-03

A Single-arm, Open-label, Multicenter, Phase Ib/II Clinical Trial of CVL237 Tablets in Combination With Serplulimab Injection for the Treatment of Advanced Solid Tumors With PTEN Loss or Low Expression

BreastGastrointestinalGynecologicThoracic

Breast Neoplasms, Uterine Cervical Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Stomach Neoplasms, Endometrial Neoplasms

NCT06075030 2026-02-27

A Study of AND017 in Cancer Related Anemic Patients Receiving Chemotherapy

36 enrolled

Classical hematology

Chemotherapy Induced Anemia

NCT06075043 2026-02-27

A Study of AND017 to Treat Cancer Related Anemia in Patients Not Receiving Chemotherapy

36 enrolled

Classical hematology

Cancer-Related Anemia

NCT07436611 2026-02-27

Rapamycin Dose-Ranging Efficacy Study in Port Wine Stains

30 enrolled

Hemangioma, Capillary

NCT07428616 2026-02-24

A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma

100 enrolled

CNS

Brain Neoplasms, Meningioma

NCT07427394 2026-02-23

SERENA-1b

24 enrolled

Advanced Breast Cancer

NCT07409103 2026-02-13

A Study to Assess the Safety and Efficacy of Different Doses of ELV001 to Treat Active Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition (START SYNERGY)

Active Rheumatoid Arthritis

NCT07406633 2026-02-12

KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting

46 enrolled

GastrointestinalSarcoma

Digestive System Neoplasms, Gastrointestinal Stromal Tumors

NCT07406724 2026-02-12

HS-IT101 Injection Versus Chemotherapy in the Treatment of Advanced Melanoma

90 enrolled

Melanoma

NCT07402070 2026-02-11

IBI363 as Neoadjuvant Therapy in Resectable Stage II-III Non-Small Cell Lung Cancer

10 enrolled

Resectable Stage II-III Non-small Cell Lung Cancer

NCT07180771 2026-01-28

A Study of Bosmolisib (BR101801) in Participants With R/R PTCL.

44 enrolled

Lymphoid

Lymphoma, T-Cell, Peripheral

NCT07370818 2026-01-27

To Evaluate the Efficacy and Safety of JPI-547 in Combination With Bevacizumab as Maintenance Therapy in Relapsed Ovarian Cancer

81 enrolled

Gynecologic

Ovarian Neoplasms

NCT07356973 2026-01-26

OPTICAL

147 enrolled

CNS

Glioblastoma

NCT07365280 2026-01-26

Neoantigen-Pulsed Autologous Dendritic Cell Vaccine Combined With Temozolomide for Newly Diagnosed Glioblastoma